Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07418034
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:24.753849+00:00
Published At
2026-02-18T00:00:00+00:00
Record Updated At
2026-02-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Head and Neck Cancer", "Head and Neck Squamous Cell Cancer", "Head and Neck Squamous Cell Carcinoma", "Oropharyngeal Carcinoma", "Oropharyngeal Squamous Cell Carcinoma (OPSCC)", "Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma", "Oropharyngeal Squamous Cell Carcinoma", "Oropharyngeal Squamous Cell Carcinoma (SCC)", "Oropharyngeal Squamous Cell Carcinoma (OPSCCA)", "Oropharyngeal Cancer", "Oropharyngeal Squamous Cell Cancer", "HPV Positive Oropharyngeal Squamous Cell Carcinoma", "HPV (Human Papillomavirus)-Associated Carcinoma", "HPV 16 Positive Oropharyngeal Tumors (OPC)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-18"
protocolSection.identificationModule.nctId
"NCT07418034"
protocolSection.identificationModule.officialTitle
"A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Head and Neck Cancer (protocolSection.conditionsModule.conditions)
  • Head and Neck Squamous Cell Cancer (protocolSection.conditionsModule.conditions)
  • Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Squamous Cell Carcinoma (OPSCC) (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Squamous Cell Carcinoma (SCC) (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Squamous Cell Carcinoma (OPSCCA) (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Cancer (protocolSection.conditionsModule.conditions)
  • Oropharyngeal Squamous Cell Cancer (protocolSection.conditionsModule.conditions)
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV (Human Papillomavirus)-Associated Carcinoma (protocolSection.conditionsModule.conditions)
  • HPV 16 Positive Oropharyngeal Tumors (OPC) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.